This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “Financial relationships between neurologists and industry: The 2015 Open Payments database,” Drs. Ahlawat and Narayanaswami analyzed payments from the pharmaceutical and device industry to neurologists in 2015 using the Centers for Medicare and Medicaid Services Open Payments database (OP). In response, Dr. Sethi argues that lack of distinction between obvious bias and potential conflicts of interest (COIs) in OP risks eroding trust in physician–patient relationships, and proposes voluntary disclosures of relevant COIs with regulatory oversight as an alternative. In contrast, Drs. Robbins and Meyer view OP as an important step towards transparency by making COIs more widely available, and towards greater divestment from financial COIs through resultant social pressure. They present data suggesting a drop in investments and financial ownership among neurologists in OP from 2013 to 2016. Responding to these comments, Drs. Ahlawat and Narayanaswami note that voluntary disclosure may be limited by failure to recognize COIs and would add to physicians' reporting burden. They acknowledge that OP is a step forward, but note that detailed clarification of the nature of payments would allow full transparency and mitigate misinterpretation. They also note that the effect of social pressure or public access to OP on divestiture would be challenging to assess.
In “Financial relationships between neurologists and industry: The 2015 Open Payments database,” Drs. Ahlawat and Narayanaswami analyzed payments from the pharmaceutical and device industry to neurologists in 2015 using the Centers for Medicare and Medicaid Services Open Payments database (OP). In response, Dr. Sethi argues that lack of distinction between obvious bias and potential conflicts of interest (COIs) in OP risks eroding trust in physician–patient relationships, and proposes voluntary disclosures of relevant COIs with regulatory oversight as an alternative.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
